EnsiliTech

PITCH

Our novel ensilication technology exploits the growth of protective silica nanoshells on the surface of vaccine components, to prevent degradation which can lead to vaccine spoilage. Once applied, our vaccines can be stored and transported without the need for cold chain infrastructure, preventing wastage, improving shelf-life and increasing vaccine accessibility globally.

Based in

Bristol

Created in

> Website

LATEST INVESTMENT

#Medtech 01.2023

£1.2M

Science Angel Syndicate, Fink Family Office, QantX, Elbow Beach Capital, Innovate UK & Angels